These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17192949)

  • 1. Comparing aromatase inhibitors in the absence of clinical trial results can be misleading.
    Goldhirsch A; Price KN
    J Surg Oncol; 2007 Mar; 95(4):355-6; author reply 357. PubMed ID: 17192949
    [No Abstract]   [Full Text] [Related]  

  • 2. Aromatase inhibitors as adjuvant therapy for breast cancer.
    Montemurro F; Aglietta M; Del Mastro L
    J Clin Oncol; 2009 May; 27(15):2566-7. PubMed ID: 19332706
    [No Abstract]   [Full Text] [Related]  

  • 3. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
    Monnier AM
    Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen.
    Booth CM; Pater JL; Goss PE
    Cancer; 2007 May; 109(9):1927-8; author reply 1928. PubMed ID: 17354227
    [No Abstract]   [Full Text] [Related]  

  • 5. The similarities of aromatase inhibitors outweigh the differences.
    Jänicke F
    Anticancer Drugs; 2008 Mar; 19 Suppl 2():S7-9. PubMed ID: 18337642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
    J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract]   [Full Text] [Related]  

  • 7. Aromatase inhibitors: an overview for surgeons.
    Bickenbach KA; Jaskowiak N
    J Am Coll Surg; 2006 Sep; 203(3):376-89. PubMed ID: 16931310
    [No Abstract]   [Full Text] [Related]  

  • 8. Reducing the risk of distant metastases in breast cancer patients: role of aromatase inhibitors.
    Del Mastro L; Clavarezza M; Venturini M
    Cancer Treat Rev; 2007 Dec; 33(8):681-7. PubMed ID: 17850976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of third-generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review.
    Poole R; Paridaens R
    Curr Opin Oncol; 2007 Nov; 19(6):564-72. PubMed ID: 17906453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?
    Dixon JM
    Breast; 2008 Aug; 17(4):353-60. PubMed ID: 18490163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is our current knowledge sufficient for the up-front use of aromatase inhibitors as adjuvant therapy for breast cancer?].
    Lefebvre-Lacoeuille C; Catala L; Descamps P
    J Gynecol Obstet Biol Reprod (Paris); 2009 Oct; 38(6):453-5. PubMed ID: 19640658
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aromatase inhibitors in advanced breast cancer].
    Spinelli GP; Tomao F; Miele E; Pasciuti G; Russillo M; Tomao S
    Recenti Prog Med; 2008 Jan; 99(1):34-8. PubMed ID: 18389871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant aromatase inhibitors and emerging quality-of-life considerations.
    Briest S; Stearns V
    Expert Rev Anticancer Ther; 2008 Jan; 8(1):1-4. PubMed ID: 18095876
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
    Tang SC
    Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer.
    Iwase H
    Breast Cancer; 2008; 15(4):278-90. PubMed ID: 18810576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK; Nielsen DL; Lindberg H; Kamby C
    Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors in the management of early breast cancer: the TEAM trial.
    Markopoulos C
    Eur J Surg Oncol; 2009 Mar; 35(3):333. PubMed ID: 18455358
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
    Dixon JM
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):453-63. PubMed ID: 18366292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aromatase inhibitors in the adjuvant treatment of postmenopausal patients with early breast cancer: a little, a lot or no way?].
    Perey L; Zaman K
    Rev Med Suisse; 2007 Oct; 3(130):2406, 2408-10, 2412. PubMed ID: 18062504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant endocrine treatment of early breast cancer.
    Lønning PE
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):223-38. PubMed ID: 17512446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.